Eramet

A massive H1 EBITDA beat, but management still has key to-dos

31/07/26 -"H1 was surprisingly strong – especially in EBITDA terms. Manganese was yet again the stronghold, with ramp-up in Lithium providing further support. However, Nickel and Mineral Sands were restrained ..."

PDF page sample
Pages
87
Language
English
Published on
31/07/26
Download
You may also be interested by these reports :
03/08/26
We have downgraded our earnings forecasts after the release of a rather disappointing set of results for H126. If profitability is on the rise, ...
31/07/26
H1 was surprisingly strong – especially in EBITDA terms. Manganese was yet again the stronghold, with ramp-up in Lithium providing further support. ...
30/07/26
H1 results were strong for Anglo and were largely driven by copper. While tailwinds in copper were obvious (i.e., better price and lower costs), the ...
30/07/26
Outokumpu reported a somewhat stronger Q226 performance, with sales increasing by 6.6% to €1.58bn and adjusted EBITDA rising to €100m. However, the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO